← Back to Clinical Trials
Recruiting NCT06894355

NCT06894355 Group Hydrotherapy Treatment for Athletes With Lower Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06894355
Status Recruiting
Phase
Sponsor Gali Dar
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-06-01
Primary Completion 2026-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
hydrotherapycontrol group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-06-01 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The effect of group hydrotherapy on chronic low back pain and function among athletes will be examined.

Eligibility Criteria

Inclusion Criteria: * Athletes who complain of low back pain for over 3 months, * VAS\>3 * train more than 5 times a week. Exclusion Criteria: * acute back pain * neurological signs (decreased muscle strength, decreased reflexes, radiating to the leg).

Contact & Investigator

Central Contact

Gali Dar, PhD

✉ galidar@yahoo.com

📞 +972505662054

Frequently Asked Questions

Who can join the NCT06894355 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06894355 currently recruiting?

Yes, NCT06894355 is actively recruiting participants. Contact the research team at galidar@yahoo.com for enrollment information.

Where is the NCT06894355 trial being conducted?

This trial is being conducted at Netanya, Israel.

Who is sponsoring the NCT06894355 clinical trial?

NCT06894355 is sponsored by Gali Dar. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology